PharMerica Comments on Federal Trade Commission Decision to Block Omnicare, Inc.’s Hostile Tender Offer

Published: Jan 30, 2012

LOUISVILLE, Ky.--(BUSINESS WIRE)--PharMerica Corporation (NYSE:PMC), a national provider of institutional pharmacy and hospital pharmacy management services, today commented on the decision by the Federal Trade Commission (FTC) to sue to block Omnicare’s (NYSE: OCR) unsolicited offer to acquire PharMerica.

Back to news